COVID-19 studies:  C19 studies: C19:  IvermectinIVM Vitamin DV.D HC QHC Q Vitamin CV.C ZincZn PVP-IPVP-I FLVFLV REGNR2 LY-CoVLY RemdesivirRMD
HCQ study #56 of 257
6/10 Early treatment study
Otea et al., medRxiv, doi:10.1101/2020.06.10.20101105 (Preprint)
A short therapeutic regimen based on hydroxychloroquine plus azithromycin for the treatment of COVID-19 in patients with non-severe disease. A strategy associated with a reduction in hospital admissions and complications.
Source   PDF   Share   Tweet
80 moderate cases, HCQ+AZ appears to reduce serious complications and death. Moderate treated cases resulted in hospitalization at the same rate as mild untreated cases suggesting efficacy.

Otea et al., 6/10/2020, preprint, 6 authors.
Details of all 257 studies    Meta analysis
Please send us corrections, updates, or comments.
Submit